Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 8, 2022
Does difference between label and actual potency of factor VIII concentrate affect pharmacokinetic-guided dosing of replacement therapy in haemophilia A?Tine M H J Goedhart, Laura H Bukkems, Iris van Moort, et al.
BMJ Open|February 16, 2022
Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: to WiN studyJessica M Heijdra, Wala Al Arashi, Nico C B de Jager, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 18, 2021
Pharmacokinetics of perioperative FVIII in adult patients with haemophilia A: An external validation and development of an alternative population pharmacokinetic modelJing Zhu, Yi Shuan Wu, Ryan J Beechinor, et al.
Journal of Thrombosis and Haemostasis : JTH|September 26, 2020
Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generationLars L F G Valke, Laura H Bukkems, Wideke Barteling, et al.
British Journal of Clinical Pharmacology|December 18, 2021
Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic-pharmacodynamic model for patients with haemophilia ALaura H Bukkems, Lars L F G Valke, Wideke Barteling, et al.
Blood Advances|March 8, 2021
Population pharmacokinetics of the von Willebrand factor-factor VIII interaction in patients with von Willebrand diseaseLaura H Bukkems, Jessica M Heijdra, Nico C B de Jager, et al.
Journal of Thrombosis and Haemostasis : JTH|September 27, 2019
One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P® /Humate P® treatment in von Willebrand disease patientsNico C B de Jager, Laura H Bukkems, Jessica M Heijdra, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 19, 2021
Principles and pitfalls in coronary vasomotor function testingRutger G T Feenstra, Andreas Seitz, Coen K M Boerhout, et al.
British Journal of Clinical Pharmacology|August 11, 2023
A new population pharmacokinetic model for recombinant factor IX-Fc fusion concentrate including young children with haemophilia BSjoerd F Koopman, Tine M H J Goedhart, Laura H Bukkems, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|March 14, 2022
Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study)Tine M H J Goedhart, Laura H Bukkems, Michiel Coppens, et al.
Pageof 3